Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Limited operates as a research-basedpharmaceutical company in Japan.
Suggest edits
Founded
1781
Raised
$57.8M
Follow us
Companies in the same industry
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Investments 13

Acquisitions 1

Apps 4

Add info
Add round
13 Feb 2020
Seqster
Seqster
Corporate round
Takeda Pharmaceutical

Takeda Pharmaceuticals Invests In Seqster 

Pulse 2.0
23 Nov 2017
Chordia Therapeutics
Chordia Therapeutics
Venture capital (Series A)
SMBC Venture Capital, Mitsubishi UFJ Capital, Takeda Pharmaceutical, +2
16 Aug 2017
Molecular Templates
Molecular Templates
$60,000,000
Post-IPO equity
Perceptive Advisors, Longitude Capital, Takeda Pharmaceutical, +2

https://www.bizjournals.com/austin/news/2017/08/16/austin-biotech-company-lands-on-nasdaq-with-fresh.html?ana=twt

bizjournals
+1
05 Jan 2017
PvP Biologics
PvP Biologics
$35,000,000
Venture capital
Takeda Pharmaceutical

PvP Biologics Raises $35M in a Lab-to-Pharma Deal with Takeda

Xconomy
+1
05 Jan 2017
Avidity Biosciences
Avidity Biosciences
$10,000,000
Venture capital (Series B)
EcoR1 Capital, Moore Venture Partners, F-Prime Capital Partners, +5

Avidity Biosciences Raises 16 Million In Series B Financing To Advance Antibody Sirna Conjugate Platform

biospace
+2
02 Dec 2016
Cerevance
Cerevance
$36,000,000
Venture capital (Series A)
Takeda Pharmaceutical, Lightstone Ventures

CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES Pharmaceutical Company Limited

takeda
16 Jun 2016
Mersana Therapeutics
Mersana Therapeutics
$33,000,000
Venture capital (Series C)
Wellington Management, NEA, Rock Springs Capital, +3

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

biospace
+1
16 Mar 2016
Outpost Medicine
Outpost Medicine
$41,000,000
Venture capital (Series A)
Adams Street Partners, Frazier Healthcare Partners, Novo A/S, +2

Outpost Medicine raises $41 mln

PE Hub
+1
17 Jan 2016
Cortexyme
Cortexyme
$15,000,000
Venture capital (Series A)
Takeda Pharmaceutical, Pfizer

Cortexyme Raises $15M in Series A Financing

FinSMEs
30 Sep 2015
Encycle Therapeutics Inc
Encycle Therapeutics Inc
$2,850,000
Venture capital
BDC Capital, MaRS Investment Accelerator Fund, Takeda Pharmaceutical, +1

Encycle Therapeutics raises $2.85 million to expand development pipeline

BetaKit
17 Jan 2014
Seattle Genetics
Seattle Genetics
$9,000,000
Post-IPO equity
Takeda Pharmaceutical
28 Mar 2011
Alnylam
Alnylam
$10,000,000
Venture capital
Takeda Pharmaceutical